Facebook Pixel Karnataka's Rise as India's Bioscience Powerhouse | Bio Spectrum - business - Les denne historien på Magzter.com
Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År

Prøve GULL - Gratis

Karnataka's Rise as India's Bioscience Powerhouse

Bio Spectrum

|

January 2026

Karnataka stands at the forefront of India’s biosciences industry, supported by progressive policies, a dynamic innovation ecosystem, and strong collaboration between industry and academia.

With advanced research capabilities, sustained global investments, and a vibrant startup environment, the state has consistently set new standards, earning it the Best Performing State Award 2025 in biosciences from BioSpectrum India.

Karnataka has emerged as one of India’s most advanced and globally connected bioscience ecosystems, driven by long-term policy vision, strong scientific institutions, innovation-led entrepreneurship, and a diversified industrial base. Over the past decade, the state has systematically built an environment that integrates research, startups, manufacturing, and global markets, positioning Karnataka as India’s biotechnology capital and a leading life sciences hub in Asia.

Bioeconomy Growth and Economic Contribution

At the core of Karnataka's bioscience leadership is the scale and consistency of its bioeconomy growth. The state's bioeconomy expanded from $22 billion in 2021 to $31 billion in 2023, reflecting a 41 per cent growth in just two years. This momentum continued into 2024, with the bioeconomy reaching approximately $32.4 billion. Karnataka now contributes nearly 21 per cent of India’s total bioeconomy, making it one of the most significant drivers of national bioscience growth.

This expansion spans multiple verticals, including biopharma, bioindustrial applications, bioagriculture, and bioservices, underscoring the resilience and diversity of the state's bioscience ecosystem.

Policy-Driven Ecosystem Development

FLERE HISTORIER FRA Bio Spectrum

Bio Spectrum

Bio Spectrum

Can India's CDMOS Lead the Next Biopharma Wave?

India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).

time to read

8 mins

March 2026

Bio Spectrum

Bio Spectrum

Telangana turns catalyst for innovation

Telangana is at a pivotal moment in its journey as a global life sciences hub.

time to read

6 mins

March 2026

Bio Spectrum

Bio Spectrum

Is AI the New Weapon in the Fight to End TB?

A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).

time to read

2 mins

March 2026

Bio Spectrum

Bio Spectrum

ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India

US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy

Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"

Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer

Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Haleon ropes in Kedar Lele as President for India Subcontinent

Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Centre revises Startup Recognition Framework to strengthen Startup India Action Plan

The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"

In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.

time to read

5 mins

March 2026

Listen

Translate

Share

-
+

Change font size